Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/126868
Title: | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 |
Author: | Pujana Genestar, M. Ángel EMBRACE Collaborators GEMO Study Collaborators Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) |
Keywords: | Càncer de mama Estrògens Breast cancer Estrogen |
Issue Date: | Apr-2016 |
Publisher: | Nature Publishing Group |
Abstract: | We analyzed 3,872 common genetic variants across the ESR1 locus (encoding estrogen receptor a) in 118,816 subjects from three international consortia. We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER+ or ER-) and human ERBB2 (HER2(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade. The best candidate causal variants for ER-tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression. |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/ng.3521 |
It is part of: | Nature Genetics, 2016, vol. 48, p. 374–386 |
URI: | http://hdl.handle.net/2445/126868 |
Related resource: | https://doi.org/10.1038/ng.3521 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) Publicacions de projectes de recerca finançats per la UE |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
DunningAM.pdf | 2.17 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License